This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Systemic lupus erythematosus, unspecified
SLE_NOS
systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
871
Check minimum number of events None
871
Include endpoints None
871
Remove individuals based on genotype QC
844
SLE_NOS
Control definitions
Control exclude
SLE_FG
Extra metadata
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M32
Name in latin
Lupus erythematosus disseminatus non specificatus
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Systemic lupus erythematosus, unspecified
based on the number of shared cases.
Broader endpoints:
- SLE, strict definition
- SLE, ICD10
- Systemic lupus erythematosus
- SLE (Finngen)
- Systemic connective tissue disorders
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 844 | 721 | 123 |
| Unadjusted prevalence (%) | 0.22 | 0.34 | 0.07 |
| Mean age at first event (years) | 47.35 | 46.38 | 53.04 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: SLE_NOS – Systemic lupus erythematosus, unspecified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Systemic lupus erythematosus, unspecified
↥Endpoint not on priority list, no data to show.